Detroit Pistons Executive Blackstone Revealed Cancer Battle
Pistons executive Michael Blackstone has shared his private Stage 4 lung cancer diagnosis with the public.
Updated on Sept. 21, 2026 in Cancer
Detroit Pistons executive Michael Blackstone has publicly revealed that he was diagnosed with Stage 4 lung cancer in 2023. Despite the cancer metastasizing to his shoulder and spine, Blackstone continues to work for the team.
Why it matters
Blackstone chose to disclose his medical journey to encourage others to remain vigilant about their health symptoms. He maintains his professional role with the Pistons to preserve a sense of normalcy amid his treatment.
The survival rate for late-stage non-small cell lung cancer stands at 12 percent. Blackstone is a non-smoker who received his diagnosis after undergoing CT scans, PET scans, and a biopsy following shoulder pain.
The players
Michael Blackstone
He is an executive vice president of basketball operations for the Detroit Pistons.
Trajan Langdon
He is the professional who hired Blackstone to join the Detroit Pistons.
The details
After experiencing persistent shoulder pain, Blackstone underwent diagnostic testing that revealed the cancer had spread to his spine and shoulder. He has since undergone aggressive chemotherapy and radiation treatments at the Mayo Clinic in Florida.
Timeline
Blackstone received his lung cancer diagnosis in 2023.
Blackstone joined the Detroit Pistons organization in 2024.
Blackstone discussed his diagnosis publicly in September 2026.
Health Landscape
This story highlights the vital role that major medical research centers like the Mayo Clinic play in providing complex care for late-stage cancer diagnoses. It underscores how advanced treatment protocols are evolving to support patients managing life-altering health conditions.
The story serves as a reminder for individuals to seek medical evaluation for persistent physical symptoms, such as the shoulder pain Blackstone experienced. It highlights the reality that lung cancer can affect non-smokers and requires proactive diagnostic screening.
The takeaway
Blackstone’s transparency serves as a reminder that cancer can impact individuals regardless of their health history. Prioritizing diagnostic checks for unusual pain remains a critical step for early detection.
Further reading
Learn more about the latest developments in oncology at the Cancer section.
